The Active Immunotherapeutics Forum will provide a new and timely annual meeting place for senior level figures driving the development of these technologies into clinically effective, cost-effective products that are acceptable to the regulator. Therapeutic vaccines against a variety of disease targets, as well as other immune modulating approaches, will be covered, with the emphasis on how clinical, regulatory and manufacturing challenges are being overcome.
The Active Immunotherapeutics Forum will run in parallel to Phacilitate's 8th annual European Vaccine Forum, with all attendees able to attend sessions taking place during both programmes, and all networking activities shared.
The Active Immunotherapeutics Forum will run in parallel to Phacilitate's 8th annual European Vaccine Forum, with all attendees able to attend sessions taking place during both programmes, and all networking activities shared.
